Streetbeat News

Regulatory

LDOS

Hackers have leaked documents from Leidos, a Pentagon IT services firm. This breach could have significant implications for the company's security reputation and its contracts with the government.

Portfolio Pulse from Benzinga Newsdesk

July 23, 2024 | 8:42 pm

NNE

SMR

Nano Nuclear Energy Inc (NASDAQ:NNE) responded to a critical short report by Hunterbrook, defending its timelines and operations. The company emphasized its adherence to regulatory guidance and accused Hunterbrook of having ulterior motives. Despite the report, NNE's stock showed resilience, though it experienced a significant drop initially.

Portfolio Pulse from Hayden Buckfire

July 23, 2024 | 8:36 pm

PAVS

Paranovus Entertainment Technology Limited (NASDAQ:PAVS) has received a notice from Nasdaq indicating that its share price has been below the $1.00 minimum bid price requirement for 30 consecutive business days, putting it at risk of delisting.

Portfolio Pulse from Benzinga Newsdesk

July 23, 2024 | 8:25 pm

EQ

Equillium Inc. has received a notice of non-compliance from Nasdaq for failing to meet the minimum bid price requirement of $1.00 for 30 consecutive days. The company has until January 15, 2025, to regain compliance, and there is no immediate effect on its listing.

Portfolio Pulse from Benzinga Newsdesk

July 23, 2024 | 8:24 pm

NUVB

Nuvation Bio Inc. (NYSE:NUVB) announced updates for its ROS1 inhibitor, taletrectinib, including upcoming presentations at ESMO 2024 and WCLC 2024. The U.S. FDA has granted Orphan Drug Designation to taletrectinib for treating multiple NSCLC indications.

Portfolio Pulse from Benzinga Newsdesk

July 23, 2024 | 8:11 pm

ACON

Aclarion has been granted European patent EP3928695 for a system and method using Magnetic Resonance Spectroscopy to diagnose back pain, including low back pain associated with Degenerative Disc Disease.

Portfolio Pulse from Benzinga Newsdesk

July 23, 2024 | 7:59 pm

APPS

CRTO

DV

GCI

GOOG

IAS

MGNI

MKTW

NWS

NYT

OB

PERI

PUBM

SCHL

TTD

Google reversed its plan to eliminate third-party cookies in Chrome, leading to gains in ad tech and publisher stocks. This decision follows industry and regulatory pushback, allowing advertisers to continue using cookies for targeted ads while giving users more control over their preferences.

Portfolio Pulse from Anusuya Lahiri

July 23, 2024 | 7:52 pm

BDX

The CDC has issued a health alert regarding a critical shortage of Becton Dickinson's Bactec blood culture media bottles. This shortage could disrupt patient care by causing delays in diagnosis, misdiagnosis, or other challenges.

Portfolio Pulse from Benzinga Newsdesk

July 23, 2024 | 7:24 pm

SPY

Senator Menendez has submitted his resignation to the U.S. Senate, as announced in a message read aloud on the Senate floor.

Portfolio Pulse from Benzinga Newsdesk

July 23, 2024 | 7:11 pm

AZN

MRK

PFE

Merck's investigational RSV treatment, clesrovimab, met its primary safety and efficacy endpoints in a late-stage study, positioning it as a competitor to Sanofi/AstraZeneca's Beyfortus and Pfizer's Abrysvo. Detailed findings will be presented at a scientific congress, and Merck plans to file the data with global regulatory authorities.

Portfolio Pulse from Vandana Singh

July 23, 2024 | 7:04 pm